See analyst estimates and all valuation multiples for Drug Delivery Systems
| Company | EV | EV/LTM Revenue | EV/LTM EBITDA |
|---|---|---|---|
| $22.5B | 9.8x | 43.8x | |
| $7.0B | 5.5x | 22.5x | |
| $5.1B | 4.3x | 16.0x | |
| $3.5B | 14.9x | 44.1x | |
| $3.1B | n/a | n/a | |
| $2.9B | 99.6x | -2.7x | |
| $1.4B | 17.0x | -478.8x | |
| $1.2B | 20.1x | -6.1x | |
| $1.0B | 38.8x | n/a | |
| $1.0B | 3.3x | n/a | |
| $916M | n/a | n/a | |
| $675M | 20.5x | -58.0x | |
| $415M | 6.3x | 38.2x | |
| $354M | 8.4x | 2.5x | |
| $253M | 24.0x | -215.6x | |
| $242M | 63.4x | -1.5x | |
| $226M | 6.1x | -10.3x | |
| $210M | n/a | n/a | |
| $196M | 3.5x | -3.7x | |
| $193M | n/a | -6.5x | |
| $135M | n/a | n/a | |
| $99.1M | 4.9x | -42.1x | |
| $89.1M | n/a | n/a | |
| $85.4M | 12.1x | n/a | |
| $82.9M | n/a | n/a | |
| $74.0M | 408.9x | n/a | |
| $71.2M | 13.0x | -3.2x | |
| $60.2M | n/a | n/a | |
| $49.2M | 17.5x | -1.6x | |
| $41.1M | 6.9x | -9.2x | |
| $36.6M | n/a | n/a | |
| $33.8M | 48.6x | n/a | |
| $31.3M | 358.3x | n/a | |
| $27.1M | 38.4x | n/a | |
| $18.9M | n/a | n/a | |
| $18.5M | n/a | -1.1x | |
| $14.0M | n/a | n/a | |
| $12.4M | n/a | n/a | |
| $12.0M | n/a | n/a | |
| $10.5M | 23.4x | n/a | |
| $4.9M | n/a | n/a | |
| -$2.3M | -0.4x | n/a | |
| -$39.2M | n/a | n/a | |
| -$71.2M | -0.6x | n/a |
Valuation multiples as of last 12 months (LTM). Financial data powered by Morningstar, Inc.
See analyst estimates and M&A multiples for Drug Delivery Systems